In HNSCC, limited data suggest that PD-L1 is expressed in tumor cells in 50-70% of the cases and that PD-1-positive tumor infiltrating lymphocytes (TIL) may be more common in cancers that are HPV positive than HPV-negative [24-30]. Here, CD274 is linked to cancer.